Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study

INTRODUCTION: There are no strong data regarding the treatment with biologics (especially for the most recent anti-IL-17 and anti-IL-23 drugs) of patients with psoriasis and concomitant viral hepatitis. We assessed the safety of biologic drugs in patients with psoriasis who are seropositive for hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gargiulo, Luigi, Pavia, Giulia, Valenti, Mario, Lleo de Nalda, Ana, Perugini, Chiara, Costanzo, Antonio, Narcisi, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110615/
https://www.ncbi.nlm.nih.gov/pubmed/35460018
http://dx.doi.org/10.1007/s13555-022-00726-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110615/
https://www.ncbi.nlm.nih.gov/pubmed/35460018
http://dx.doi.org/10.1007/s13555-022-00726-w

Ejemplares similares